PSS Reaches Basic Agreement with Nordiag ASA on Development of Reagents and their Protocols for Next Generation Sequencer

Precision System Science, Co., Ltd (PSS) announced today that PSS and Nordiag ASA (Oslo, Norway) have entered into basic development agreement of reagents for next generation sequencer, development of such reagents protocols for SX-8G Compact and the distribution of the reagents by both companies. The genetic analysis market, using next generation sequencer, is currently $1 [...]

Implant Sciences Retains Former Assistant Secretary of Defense Paul McHale

WILMINGTON, MA - Implant Sciences Corporation (PINKSHEETS: IMSC) (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced the Company has retained the consulting services of former Assistant Secretary of Defense Paul McHale. Mr. McHale is the president of Civil Support International LLC, a consulting firm offering advisory services [...]

Sigma-Aldrich Announces Organizational Changes

ST. LOUIS - Sigma-Aldrich® Corporation (Nasdaq: SIAL) announces the following executive leadership appointments intended to more closely align its corporate structure with its strategic plan. Frank Wicks, President Research, will assume responsibility for the entire portfolio of Research products, including those in Research Essentials, Research Specialties and Research Biotech. This newly combined Research strategic business [...]

TSA Certifies Morpho Detection’s High-Speed Checked Bag Explosives Detection Solution

Newark, Calif. - Morpho Detection, Inc., part of Morpho, Safran group’s security business, today announced its CTX 9800 DSi™ explosives detection system (EDS) has been certified by the Transportation Security Administration (TSA) in a high-speed configuration that processes in excess of 40 percent more bags than its fastest previously-certified system while continuing to provide high-resolution [...]

Leading Genomic Services Provider Selects Fluidigm Access Array™ System

IMGM Laboratories GMBH has purchased a Fluidigm Access Array™ System to use in its development and validation of targeted re-sequencing applications services. IMGM is the first Genomic Services Provider to offer the combination of the Fluidigm Access Array technology in conjunction with Roche's 454 Next-Generation Sequencing Systems to its customers in Germany. The Fluidigm Access [...]

ACEA Biosciences, Inc. Announces New Patent; Broad Claims Granted for Cytotoxicity Profiling and Chemical Compound Testing on the xCELLigence System

SAN DIEGO, Calif. - ACEA Biosciences, Inc., a pioneer in the development of high-performance microelectronic systems for cell-based assays, diagnostics, and pharmaceutical research, is pleased to report the issuance of a new U. S. Patent for chemical compound screening, with important applications in the development of new pharmaceutical products. Testing and profiling of these candidate [...]

Fluidigm Corporation Announces Exercise of Underwriters’ Over-Allotment Option

SOUTH SAN FRANCISCO, Calif. - Fluidigm Corporation (NASDAQ:FLDM) today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 833,750 shares of Fluidigm common stock at $13.50 per share, less underwriting discounts and commissions. Together with the shares sold pursuant to the over-allotment option, Fluidigm [...]

METTLER TOLEDO Announces the Release of the New Excellence XA Balances Line for Academia

COLUMBUS, Ohio - METTLER TOLEDO is pleased to introduce a new line of Excellence XA Analytical and Precision Balances. Ideal for use in Academia, METTLER TOLEDO’s new Excellence XA Balance line combines fundamental functionality with high weighing performance to deliver a range of balances that are straightforward and easy to use but still excel in [...]

Genovis Acquires Exclusive License for Upconverting Nanoparticles and Plans Launch Within 1 Year

Genovis has acquired an exclusive license for a new technology that uses so-called upconverting nanoparticles as contrast agents in optical biomedical imaging. Genovis is acquiring the license from Lumito, a LUAB company, including an option to acquire the technology as a whole. The license grants exclusive rights to upconverting nanoparticles and to the technology required [...]

Labvantage Slected to Support Global Medical Technology Company’s Worldwide Process Harmonization Initiatives

Bridgewater, NJ. - LABVANTAGE Solutions, Inc., the leading provider of browser-based laboratory information management solutions (LIMS), today announced that a global medical technology company (the Company) has extended a three-year preferred vendor agreement with LABVANTAGE. CENTRALIZED, BEST PRACTICES BASED DEPLOYMENT In an effort to realize a significant cost reduction and minimize potential risk, the Company [...]

Access IBO on Knowledge Center